Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria-Reference-Cited by-同舟云学术

Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria

Published:2018-10 Issue:9 Volume:36 Page:857-864
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Isabella Vincent M,Ha Binh N,Castillo Mary Joan,Lubkowicz David J,Rowe Sarah E,Millet Yves A,Anderson Cami L,Li Ning,Fisher Adam B,West Kip A,Reeder Philippa J,Momin Munira M,Bergeron Christopher G,Guilmain Sarah E,Miller Paul F,Kurtz Caroline B,Falb Dean

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

http://www.nature.com/articles/nbt.4222.pdf

Reference51 articles.

1. de Groot, M.J., Hoeksma, M., Blau, N., Reijngoud, D.J. & van Spronsen, F.J. Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses. Mol. Genet. Metab. 99 (Suppl. 1), S86–S89 (2010).

2. Anderson, P.J. et al. Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels? Dev. Neuropsychol. 32, 645–668 (2007).

3. Bilder, D.A. et al. Psychiatric symptoms in adults with phenylketonuria. Mol. Genet. Metab. 108, 155–160 (2013).

4. Romani, C. et al. The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: Effects across tasks and developmental stages. Neuropsychology 31, 242–254 (2017).

5. Vockley, J. et al. Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet. Med. 16, 188–200 (2014).

Cited by 405 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide GLP-1 receptor agonists: From injection to oral delivery strategies;Biochemical Pharmacology;2024-11

2. In vivo detection of endogenous toxic phenolic compounds of intestine;Journal of Hazardous Materials;2024-10

3. Modified montmorillonite armed probiotics with enhanced on-site mucus-depleted intestinal colonization and H2S scavenging for colitis treatment;Journal of Controlled Release;2024-10

4. Rapid Fingerprinting of Urinary Volatile Metabolites and Point-of-Care Diagnosis of Phenylketonuria on a Patterned Nanorod Sensor Array with Multiplexed Surface-Enhanced Raman Scattering Readouts;Analytical Chemistry;2024-08-29

5. Towards Understanding Tumour Colonisation by Probiotic Bacterium E. coli Nissle 1917;Cancers;2024-08-26